stockrowEquillium, Inc.
EQEquillium, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $41.1 million, up 13.9% from fiscal 2023.
- Revenue
- −52.3%
- EPS
- +75.0%
- Free cash flow
- −38.7%
Quarter to June 2026, against a year earlier
Follow EQ
Alert me
Equillium, Inc. (EQ) Return on invested capital
Equillium, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from 0.00% (fiscal 2025) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 0.00% | 0.00 |
| FY2024 | 0.00% | 0.00 |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | 0.00 |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| VXRT VAXART, INC. compare | 2,515.1% |
| ICCC ImmuCell Corporation compare | 7.84% |
| PMVP PMV Pharmaceuticals, Inc. compare | 0.00% |
| GNLX Genelux Corporation compare | 0.00% |
| BDTX Black Diamond Therapeutics, Inc. compare | 0.00% |
| PLYX Polaryx Therapeutics, Inc. compare | 0.00% |
| EQ Equillium, Inc. | 0.00% |
| SEER Seer, Inc. compare | −72.5% |
| HURA TuHURA Biosciences, Inc. compare | −74.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)